Evaluation of Alirocumab Versus Ezetimibe on Top of Statin in Asia in High Cardiovascular Risk Patients With Hypercholesterolemia
Clinical trial NCT02715726 · COMPLETED
Trial details
- NCT number
- NCT02715726
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-27
- Primary completion
- 2018-08-06
- Enrollment
- 615
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.